Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New Haven, Connecticut 06511


Purpose:

CP-945,598 is eliminated primarily by enzyme CYP3A. Grapefruit juice may affect the activity of CYP3A and alter the amount of CP-945,598 in the blood. This study will therefore compare the time course of drug concentrations in the body, safety and tolerability of CP-945,598 given with or without grapefruit juice in healthy obese/overweight subjects.


Criteria:

Inclusion Criteria: 1. Healthy male and female subjects between the ages of 18 and 55 years. 2. Body Mass Index (BMI) of 27 to 40 kg/m2. 3. Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures. Exclusion Criteria: - Non-prescribed use of drugs of abuse/ recreational drugs; - Recent treatment with experimental drugs or herbal experiments; - EKG and blood pressure parameters falling outside of protocol-specified limits; - History of regular alcohol or tobacco use exceeding protocol-specified limits; grapefruit juice intolerance.


NCT ID:

NCT00645216


Primary Contact:

Study Director
Pfizer CT.gov Call Center
Pfizer


Backup Contact:

N/A


Location Contact:

New Haven, Connecticut 06511
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.